Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind, Multiple-site, Placebo-Controlled Study, Comparing the Efficacy and Safety of SUBA™-Itraconazole Capsules Compared to SPORANOX® (Itraconazole) Capsules in the Treatment of Onychomycosis of the Toenail

NCT00791219 is registered in ClinicalTrials.gov with Halcygen Pharmaceuticals Limited as lead sponsor.

NCT NCT00791219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00791219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind, Multiple-site, Placebo-Controlled Study, Comparing the Efficacy and Safety of SUBA™-Itraconazole Capsules Compared to SPORANOX® (Itraconazole) Capsules in the Treatment of Onychomycosis of the Toenail
Lead sponsor
Halcygen Pharmaceuticals Limited
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
December 31, 2010
Enrollment
175 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis